Based on these findings, our results suggest that the abnormal expression of placental ABCA1 may induce lipid metabolism disorder in the placenta, which leads to the occurrence of SPD, and there may be two mechanisms by which ABCA1 affects the SPD risk. This evidence concerns the gene ABCA1 and Disorder of lipid metabolism.